|
Concord Biotech Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
14734.15 Cr.
|
P/BV
|
8.13
|
Book Value (Rs.)
|
173.27
|
|
52 Week High/Low (Rs.)
|
2452/1345
|
FV/ML
|
1/1
|
P/E(X)
|
39.65
|
|
Bookclosure
|
03/09/2025
|
EPS (Rs.)
|
35.52
|
Div Yield (%)
|
0.76
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 10.00 |
| | | | | |
| | | | | |
| INCOME | | | | |
| Revenue From Operations [Net] | 1179.82 | 998.06 | 830.63 | 708.44 |
| Other Operating Revenues | 20.27 | 18.88 | 22.54 | 4.49 |
| Total Operating Revenues | 1200.09 | 1016.94 | 853.17 | 712.93 |
| | | | | |
| Other Income | 44.45 | 33.78 | 35.31 | 23.42 |
| Total Revenue | 1244.53 | 1050.72 | 888.48 | 736.35 |
| | | | | |
| EXPENSES | | | | |
| Cost Of Materials Consumed | 264.31 | 184.54 | 167.07 | 157.26 |
| Purchase Of Stock-In Trade | 55.99 | 56.74 | 28.77 | 30.73 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -14.79 | -12.08 | -15.63 | -23.98 |
| Employee Benefit Expenses | 138.93 | 123.05 | 110.28 | 95.69 |
| Finance Costs | 0.53 | 2.55 | 4.51 | 5.48 |
| Depreciation And Amortisation Expenses | 54.37 | 53.59 | 54.03 | 50.05 |
| Other Expenses | 249.31 | 233.14 | 219.39 | 179.95 |
| Total Expenses | 748.66 | 641.53 | 568.42 | 495.19 |
| | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 495.88 | 409.19 | 320.05 | 241.16 |
| | | | | |
| Profit/Loss Before Tax | 495.88 | 409.19 | 320.05 | 241.16 |
| | | | | |
| Tax Expenses-Continued Operations | | | | |
| Current Tax | 118.96 | 99.83 | 79.53 | 58.49 |
| Deferred Tax | 3.95 | 4.63 | 2.38 | 3.71 |
| Tax For Earlier Years | 0.00 | 0.00 | 0.02 | 0.39 |
| Total Tax Expenses | 122.91 | 104.46 | 81.93 | 62.59 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 372.96 | 304.73 | 238.13 | 178.57 |
| | | | | |
| Profit/Loss From Continuing Operations | 372.96 | 304.73 | 238.13 | 178.57 |
| | | | | |
| Profit/Loss For The Period | 372.96 | 304.73 | 238.13 | 178.57 |
| Share Of Profit/Loss Of Associates | -1.32 | 3.37 | 1.96 | -3.64 |
| Consolidated Profit/Loss After MI And Associates | 371.64 | 308.10 | 240.09 | 174.93 |
| | | | | |
| OTHER INFORMATION | | | | |
| | | | | |
| EARNINGS PER SHARE | | | | |
| Basic EPS (Rs.) | 35.52 | 29.45 | 22.95 | 16.72 |
| Diluted EPS (Rs.) | 35.52 | 29.45 | 22.95 | 16.72 |
| | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | |
| Equity Share Dividend | 91.54 | 71.45 | 53.56 | 70.52 |
